Rossari Biotech Limited
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printi… Read more
Rossari Biotech Limited (ROSSARI) - Total Liabilities
Latest total liabilities as of September 2025: ₹8.36 Billion INR
Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has total liabilities worth ₹8.36 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Rossari Biotech Limited - Total Liabilities Trend (2017–2025)
This chart illustrates how Rossari Biotech Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Rossari Biotech Limited Competitors by Total Liabilities
The table below lists competitors of Rossari Biotech Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EVA Precision Industrial Holdings Limited
F:GZT
|
Germany | €4.29 Billion |
|
KlaraBo Sverige AB Series B
ST:KLARA-B
|
Sweden | Skr5.87 Billion |
|
Celtic plc
PINK:CLTFF
|
USA | $89.89 Million |
|
Gotland Rederi AB Series B
ST:GOTL-B
|
Sweden | Skr1.23 Billion |
|
Ubiquoss Inc
KQ:264450
|
Korea | ₩30.50 Billion |
|
Kejuruteraan Asastera Bhd
KLSE:0193
|
Malaysia | RM317.06 Million |
|
Summit Bank Group Inc
PINK:SBKO
|
USA | $1.13 Billion |
|
Sea1 Offshore Inc.
OL:SEA1
|
Norway | Nkr405.15 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Rossari Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Rossari Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Rossari Biotech Limited (2017–2025)
The table below shows the annual total liabilities of Rossari Biotech Limited from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹7.11 Billion | +35.53% |
| 2024-03-31 | ₹5.24 Billion | +15.92% |
| 2023-03-31 | ₹4.52 Billion | +0.19% |
| 2022-03-31 | ₹4.52 Billion | +195.96% |
| 2021-03-31 | ₹1.53 Billion | -17.45% |
| 2020-03-31 | ₹1.85 Billion | +46.66% |
| 2019-03-31 | ₹1.26 Billion | +61.85% |
| 2018-03-31 | ₹778.70 Million | +13.00% |
| 2017-03-31 | ₹689.09 Million | -- |